S.E.A. Medical Systems Welcomes New Board Members
S.E.A. Medical Systems, Inc., a privately held medical device company dedicated to making intravenous drug delivery safer for patients, recently welcomed two additions to their Board of Directors.
Featured Articles
New Inflatable Device Targets Heart Disease
U.S. researchers say a new technology can safely place sensitive electronics inside the human heart for better diagnosis of heart rhythm irregularities.
Global In Vitro Diagnostic Market Analysis
A new market research report on the In Vitro Diagnostic market is now available in the reportlinker.com catalogue.
OneMedForum NY 2011 Trans-Atlantic Conference Promises Quality Connections
OneMedPlace is gearing up for OneMedForum NY 2011, the company’s 2nd annual Trans-Atlantic Conference to be held June 23-24 , 2011 in New York City.
Accord Biosciences Receives $1.3M NIH SBIR Grant To Develop Pulmonary Hypertension Diagnostic
Last year, Accord Biosciences was awarded a Phase II National Institutes of Health Small Business Innovation Research grant of $1.3M to develop a point-of-care diagnostic for pulmonary arterial hypertension.
Compumedics System: World’s first accredited and paperless sleep lab
Compumedics Grael High-Definition PSG/EEG system and their ProFusion nexus Lab Management system, is now the world’s first accredited and paperless sleep lab’s database monitoring technology of choice.
Second Sight Develops A Second Chance for the Blind
An implant designed to restore a degree of sight to people with advanced retinal degenerative diseases has been approved for sale in the European Economic Area.
The Neurology Market: A Glance (video)
The plethora of recent reports of new genes and pathways linked to neurological diseases shows that the underlying causes of these diseases are far from certain.
Akonni Biosystems Inks Agreement with Lead Medical Research Laboratory
Akonni Biosystems, a molecular diagnostics company that develops rapid, low-cost and highly scalable solutions for infectious disease testing has signed a license agreement with the U.S. Army Medical Research Institute of Infectious Diseases.
EpiCept Corporation Announces Year End Results and Updates On Clinical Trials Surrounding Cancer Treatment
EpiCept Corporation recently announced operating and financial results for the year 2010, and provided an update on its key business initiatives.